Compare AbCellera Biologics Inc (ABCL) vs Walt Disney Co (DIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Walt Disney Co — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while Walt Disney Co trades at $103.22 (market cap $178.76B). The key difference: Walt Disney Co is far larger — about 59.8× AbCellera Biologics Inc's market cap, and Walt Disney Co pays a 1.45% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | DIS | |
|---|---|---|
Market Cap | $2.99B | $178.76B |
Sector | Health | Media |
52-Week High | $9.76 | $118.86 |
52-Week Low | $2.78 | $92.40 |
Enterprise Value | $2.58B | $219.62B |
Volume | — | 7,546,013 |
Dividend Yield | — | 1.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Disney (DIS) trades at $103.51, down 1.32% on the day, with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with four consecutive quarterly earnings beats, revenue growth to $94.43B in 2025, and improving profit margins. Recent news highlights advertising opportunities from major events and ongoing FCC regulatory challenges.
Outlook remains positive with analyst consensus target of $126 representing 22% upside potential. Key opportunities include streaming growth and theme park investments, while risks involve regulatory disputes and box office performance variability. Wall Street maintains strong buy sentiment with 62.5% of analysts recommending purchase.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Walt Disney Co
The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.
Read more on DIS →
